Soleno earnings release
WebAug 10, 2024 · Soleno intends to meet with regulatory authorities later this year to determine next steps Closed public offering of common stock in June 2024, with net proceeds of approximately $53.7 million ... WebView the latest Soleno Therapeutics Inc. (SLNO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Soleno earnings release
Did you know?
WebApr 2, 2024 · Soleno Therapeutics (SLNO) will release its next earnings report on Apr 3, 2024. In the last quarter Soleno Therapeutics reported -$0.91 EPS in relation to -$0.76 … Web2 days ago · SOLENO THERAPEUTICS, INC. company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: SLNO Nasdaq
WebJul 27, 2024 · Soleno Therapeutics, Inc. SLNO will provide updates on its pipeline candidates when it releases second-quarter 2024 results. The company has a mixed track record, … WebMar 22, 2024 · The following information was filed by Soleno Therapeutics Inc (SLNO) on Tuesday, March 21, 2024 as an 8K 2.02 statement, which is an earnings press release …
WebFind the latest Earnings Report Date for Soleno Therapeutics, Inc. Common Stock (SLNO) ... Latest Press Release Published. Published. Earnings Per Share Estimated Reported. WebJun 9, 2024 · Shares in Soleno Therapeutics, Inc. are plunging over 45% in Tuesday’s pre-market trading after the company announced disappointing top-line results from its Phase III trial evaluating once-daily Diazoxide Choline Controlled Release (DCCR) tablets for patients with Prader-Willi Syndrome (PWS).The Destiny PWS study did not meet its primary …
WebFeb 24, 2024 · The Soleno Therapeutics Inc stock price gained 1.42% on the last trading day (Thursday, 2nd Feb 2024), rising from $2.82 to $2.86. During the last trading day the stock …
WebApr 14, 2024 · Earnings and Valuation. Earnings Growth. Earnings for Soleno Therapeutics are expected to grow in the coming year, from ($1.62) to ($0.47) per share. Price to … botbuilders.comWebMar 21, 2024 · December 31, 2024 December 31, 2024 Assets Current assets Cash and cash equivalents $ 14,602 $ 21,304 Prepaid expenses and other current assets hawthorne ca directionsWebJul 27, 2024 · We expect Soleno (SLNO) to provide its clinical program updates when its releases second-quarter 2024 results. botbuilders llcWebSOLENO THERAPEUTICS INC : Press releases relating to SOLENO THERAPEUTICS INC Investor relations Nasdaq: Nasdaq hawthorne ca dmv officeWebNov 9, 2024 · Soleno Therapeutics (SLNO) reported a 3rd Quarter September 2024 loss of $0.76 per share on revenue of $0.0 million. ... Earnings Release. Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results. REDWOOD CITY, Calif., Nov. 09, ... bot builder githubWebQ1 Earnings. Press Release. Form 10-Q. Q2 Earnings. Press Release. Form 10-Q. Q3 Earnings. Press Release. Form 10-Q. Q4 Earnings. Press Release. 2024. Q1 Earnings. Press Release. Form 10-Q. Q2 Earnings. Press Release. Form 10-Q. Q3 Earnings. Press Release. … botbuilder pythonWebDec 19, 2024 · 19 December 2024, 8:00 am · 5-min read. Soleno Therapeutics. Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala … hawthorne ca dmv